Caitta Inc.

Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB) headquartered in Herndon, Virginia, supplies scientific instrumentation and analytical equipment to federal agencies as a prime contractor on 310 awards spanning laboratory equipment procurement, specialized technical consulting, and professional services delivery. The company operates exclusively as a prime (100% of awards) with no subcontractor footprint; it competes predominantly under small business set-asides, with recurring EDWOSB and 8(a) sole-source designations across its prime portfolio.

Caitta's capability portfolio centers on the procurement and delivery of high-performance analytical instruments—mass spectrometers, liquid chromatography systems, gas chromatography analyzers, ion chromatographs, and related laboratory equipment—to support federal research, regulatory, and diagnostic missions. Representative work includes a $1.52 million total small business set-aside purchase order from the FDA for a liquid chromatography coupled with high-resolution-accurate mass tandem mass spectrometer system (awarded September 2024), a $1.34 million 8(a) sole-source definitive contract with the FDA for expert services in SharePoint, expert witnesses, and data integrity (awarded June 2023), a $4.09 million 8(a) sole-source purchase order from the National Center for Advancing Translational Sciences for administrative support services (awarded September 2021), and a $2.13 million 8(a) sole-source purchase order from the NIH Clinical Center for on-call radiologist services (awarded April 2022). The company also holds a $2 million GSA Federal Supply Schedule contract (awarded March 2022, expiring March 2027) covering 28 labor categories spanning epidemiology support, public health analysis, project management, functional analysis, risk assessment, research science, and evaluation services, with hourly rates from $48.56 to $413.11 across education levels from high school through Ph.D. and no security-cleared roles offered.

Customer concentration is heavily weighted toward civilian health and research agencies. The top five funding agencies account for 65% of awards by count and 74% of combined potential value, anchored by the Department of Health and Human Services Food and Drug Administration (116 awards, $43.7 million combined potential value), followed by HHS Centers for Disease Control and Prevention Pittsburgh (19 awards, $10 million), HHS National Institutes of Health Clinical Center (33 awards, $6.7 million), HHS National Heart Lung and Blood Institute (9 awards, $5.6 million), and the Department of Commerce National Institute of Standards and Technology (18 awards, $4.9 million). The FDA concentration—37% of awards and 46% of potential value—reflects Caitta's strategic focus on pharmaceutical regulatory testing, product safety analysis, and analytical instrumentation support to that agency's divisions across laboratories in St. Louis, College Park, Silver Spring, and Calverton, Maryland.

Vehicle position and recent activity show material recompete exposure. Caitta holds positions on five parent vehicles: an Indefinite Delivery Contract with HHS (HHSF223201710025I) with 14 task orders ($4.1 million combined potential value), an IDC with HHSD (75F40119D10017) with 10 task orders ($3.2 million), an IDC with HHSD (HHSD200201795136I) with 3 task orders ($2 million), a GWAC (75F40120D00007) with 2 task orders ($358 thousand), and the GSA Multiple Award Schedule with 1 task order ($229 thousand). Award volume has contracted over the past two years—from 19 awards in 2023 and 17 in 2024 to 9 in 2025 and 4 as of mid-2026—and fourteen awards (combined potential value $11.2 million) reach ultimate completion within the next twenty-four months, presenting significant recompete risk for the vendor and recompete opportunity for competitors.

Service Contract Inventory data, which covers federal service contracts above the $150,000 threshold and excludes goods procurement, shows Caitta invoiced $8.5 million across FY2022–FY2024 on SCI-reportable prime contracts. FY2022 invoicing reached $2.6 million across 15.1 FTEs; FY2023 invoicing was $3.2 million across 15.6 FTEs; FY2024 invoicing was $2.7 million across 12.6 FTEs, reflecting a declining workforce trajectory on service-reportable work. Government-paid hourly rates on prime service contracts show a median of $127.15 per hour, with the 10th percentile at $64.19 per hour and the 90th percentile at $327.57 per hour, spanning from entry-level support roles through senior technical specialists. Across SCI-reportable prime contracts, Caitta self-performed all contractor hours with zero subcontractor engagement (0% sub-hours share), reflecting a fully captive delivery model on service work and no teaming relationships on the SCI-visible footprint.

Award data spans 52 distinct customer agencies across 133 awards classified under NAICS 334516 (Analytical Laboratory Instrument Manufacturing), 56 under All Other Professional, Scientific, and Technical Services, and 28 under Other Scientific and Technical Consulting Services, with procurement strategy heavily concentrated in Laboratory Equipment and Supplies (PSC group, 148 awards). The company's corporate structure includes a subsidiary, AC Integrity Partners LLC, designated as a self-certified Small Disadvantaged Business and Joint Venture Economically Disadvantaged Women-Owned Small Business. Combined potential value across the full 310-award footprint is $95.5 million, with $75.7 million obligated (79% of potential). The recompete cliff and contracting trend—declining award volume and moderate SCI invoicing concentration—signal a mature, niche-focused vendor anchored to a narrow customer base and specialized capability set in scientific equipment procurement and support services for the federal health and research establishment.

?IT Shared Services

?IT help desk and call center services

?Server, network & desktop management

?Complete and partial infrastructure outsourcing (Managed Services)

?Preventative infrastructure maintenance